1. Home
  2. ACHL vs VIVK Comparison

ACHL vs VIVK Comparison

Compare ACHL & VIVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHL
  • VIVK
  • Stock Information
  • Founded
  • ACHL 2016
  • VIVK 2006
  • Country
  • ACHL United Kingdom
  • VIVK United States
  • Employees
  • ACHL N/A
  • VIVK N/A
  • Industry
  • ACHL Biotechnology: Biological Products (No Diagnostic Substances)
  • VIVK Oilfield Services/Equipment
  • Sector
  • ACHL Health Care
  • VIVK Energy
  • Exchange
  • ACHL Nasdaq
  • VIVK Nasdaq
  • Market Cap
  • ACHL 46.0M
  • VIVK 50.4M
  • IPO Year
  • ACHL 2021
  • VIVK N/A
  • Fundamental
  • Price
  • ACHL $1.38
  • VIVK $0.88
  • Analyst Decision
  • ACHL Buy
  • VIVK
  • Analyst Count
  • ACHL 2
  • VIVK 0
  • Target Price
  • ACHL $4.00
  • VIVK N/A
  • AVG Volume (30 Days)
  • ACHL 1.9M
  • VIVK 34.4K
  • Earning Date
  • ACHL 04-03-2025
  • VIVK 04-16-2025
  • Dividend Yield
  • ACHL N/A
  • VIVK N/A
  • EPS Growth
  • ACHL N/A
  • VIVK N/A
  • EPS
  • ACHL N/A
  • VIVK N/A
  • Revenue
  • ACHL N/A
  • VIVK $61,991,772.00
  • Revenue This Year
  • ACHL N/A
  • VIVK N/A
  • Revenue Next Year
  • ACHL N/A
  • VIVK N/A
  • P/E Ratio
  • ACHL N/A
  • VIVK N/A
  • Revenue Growth
  • ACHL N/A
  • VIVK 0.33
  • 52 Week Low
  • ACHL $0.63
  • VIVK $0.67
  • 52 Week High
  • ACHL $1.76
  • VIVK $3.45
  • Technical
  • Relative Strength Index (RSI)
  • ACHL 72.41
  • VIVK 37.86
  • Support Level
  • ACHL $1.10
  • VIVK $0.78
  • Resistance Level
  • ACHL $1.41
  • VIVK $1.02
  • Average True Range (ATR)
  • ACHL 0.02
  • VIVK 0.08
  • MACD
  • ACHL 0.00
  • VIVK 0.00
  • Stochastic Oscillator
  • ACHL 90.48
  • VIVK 37.69

About ACHL Achilles Therapeutics plc

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

About VIVK Vivakor Inc.

Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is primarily focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services.

Share on Social Networks: